Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 06, 2022

Long-Term (5-Year) Outcomes of Transcatheter vs Surgical AVR in Intermediate-Risk Patients

JAMA Cardiology


Additional Info

JAMA Cardiology
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial
JAMA Cardiol 2022 Aug 24;[EPub Ahead of Print], NM Van Mieghem, GM Deeb, L Søndergaard, E Grube, S Windecker, H Gada, M Mumtaz, PS Olsen, JC Heiser, W Merhi, NS Kleiman, SJ Chetcuti, TG Gleason, JS Lee, W Cheng, RR Makkar, J Crestanello, B George, I George, S Kodali, SJ Yakubov, PW Serruys, R Lange, N Piazza, MR Williams, JK Oh, DH Adams, S Li, MJ Reardon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading